AG
MJN

Artal Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Artal Group’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-150,000
Closed -$12.5M – 109
2014
Q1 		$12.5M Buy
+150,000
New +$12.2M 0.45% 48

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Artal Group's MJN Position: Q2 2014 in Review

Artal Group sold out of Mead Johnson Nutrition Company (MJN) in Q2 2014, closing a stake of 150,000 shares — an estimated $12.5M sold.

Artal Group first reported a position in MJN in Q1 2014 and held it in 1 quarter. The position peaked at $12.5M in Q1 2014. 514 funds tracked by Wall St. Rank hold MJN as of Q2 2014.

  • Artal Group reported no remaining Mead Johnson Nutrition Company position as of Q2 2014 after selling out during the quarter.
  • Artal Group sold 150,000 Mead Johnson Nutrition Company shares in Q2 2014, an estimated $12.5M.
  • Artal Group first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 1 quarter.
  • Artal Group's Mead Johnson Nutrition Company position peaked at $12.5M in Q1 2014.
  • 514 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2014.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.